Recent advances in the treatment of asthma and chronic obstructive pulmonary disease (COPD) have emerged with the introduction of benralizumab, an injection that has proven to outperform traditional ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease.

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

A Perspective published in PNAS Nexus summarizes the risks of bypassing natural selection when using assisted reproductive ...

Around 50% of asthma attacks and 30% of COPD attacks are ... than is currently approved in Fasenra (a 100mg subcutaneous injection plus the current standard therapy of 30mg prednisolone orally ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

A Perspective summarizes the risks of bypassing natural selection when using assisted reproductive technologies (ART) in ...

INHALE-1 is a 26-week, open-label clinical trial that randomized 230 subjects aged 4-17 years with type 1 or type 2 diabetes to either inhaled pre-meal insulin or multiple daily injections (MDI) of ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma symptoms and to help prevent asthma ...

MILLIONS have been urged to protect themselves a “tidal wave” of flu and winter bugs in the days before Christmas. Eligible ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...